Cornelius F. Waller

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim et al. · The Lancet Oncology · 2018 · 576 citations · Full text

Medicine, Oncology, Pharmacology +8

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Valerie Oberhardt, Hendrik Luxenburger, Janine Kemming et al. · Nature · 2021 · 427 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

Benjamin Hanfstein, Marc Müller, Rüdiger Hehlmann et al. · Leukemia · 2012 · 417 citations

Life Sciences, Molecular Biology, Oncology +16

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Jonas A. Hosp, Ganna Blazhenets, Tobias Bormann et al. · Brain · 2021 · 405 citations · Full text

Medicine, Neurology, Neuroscience +17

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Isabel Schulien, Janine Kemming, Valerie Oberhardt et al. · Nature Medicine · 2020 · 399 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10